Molecular Remission Confirmed by Monitoring a PTPN11 Mutation in Myeloid Leukemia of Down Syndrome Treated With Reduced-Intensity Stem Cell Transplantation: A Case Report.
증례보고
0/5 보강
APA
Yoshida T, Muramatsu H, et al. (2026). Molecular Remission Confirmed by Monitoring a PTPN11 Mutation in Myeloid Leukemia of Down Syndrome Treated With Reduced-Intensity Stem Cell Transplantation: A Case Report.. Pediatric blood & cancer, 73(2), e70077. https://doi.org/10.1002/1545-5017.70077
MLA
Yoshida T, et al.. "Molecular Remission Confirmed by Monitoring a PTPN11 Mutation in Myeloid Leukemia of Down Syndrome Treated With Reduced-Intensity Stem Cell Transplantation: A Case Report.." Pediatric blood & cancer, vol. 73, no. 2, 2026, pp. e70077.
PMID
41454824 ↗
같은 제1저자의 인용 많은 논문 (5)
- Dynamic changes in serum HER2-peptide-specific autoantibodies predict response to neoadjuvant therapy in HER2-positive breast cancer.
- Safety and Antitumor Activity of Farletuzumab Ecteribulin in Patients With NSCLC: Phase I Expansion Results.
- Examination of Inferior Mesenteric Artery Node Metastasis in Left-Sided Colorectal Cancer: A Retrospective Cohort Analysis.
- Diagnostic Ability of Magnifying Endoscopy Compared to Biopsy Examination for Early Gastric Cancer prior to Endoscopic Submucosal Dissection.
- Administration of Nivolumab plus FOLFOX Therapy to a Patient with Gastric Cancer Undergoing Hemodialysis: A Case Report.